Fmr LLC Sells 2,923,144 Shares of Outset Medical, Inc. (NASDAQ:OM)

FMR LLC trimmed its holdings in shares of Outset Medical, Inc. (NASDAQ:OM - Free Report) by 38.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,773,776 shares of the company's stock after selling 2,923,144 shares during the period. FMR LLC owned 9.09% of Outset Medical worth $3,232,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of OM. Price T Rowe Associates Inc. MD increased its holdings in Outset Medical by 75.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 82,636 shares of the company's stock valued at $184,000 after purchasing an additional 35,495 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in Outset Medical by 60.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 1,515,126 shares of the company's stock valued at $5,833,000 after purchasing an additional 570,281 shares in the last quarter. Griffin Asset Management Inc. increased its holdings in Outset Medical by 7.8% during the 2nd quarter. Griffin Asset Management Inc. now owns 105,514 shares of the company's stock valued at $406,000 after purchasing an additional 7,600 shares in the last quarter. Summit Securities Group LLC acquired a new stake in shares of Outset Medical in the 2nd quarter valued at $105,000. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of Outset Medical in the 2nd quarter valued at $731,000.

Outset Medical Trading Down 8.3 %

Shares of NASDAQ OM traded down $0.10 during midday trading on Friday, hitting $1.11. The stock had a trading volume of 641,266 shares, compared to its average volume of 1,304,037. The company's 50-day simple moving average is $0.79 and its 200 day simple moving average is $1.85. The firm has a market cap of $58.32 million, a P/E ratio of -0.40 and a beta of 2.16. Outset Medical, Inc. has a fifty-two week low of $0.44 and a fifty-two week high of $6.37. The company has a debt-to-equity ratio of 4.12, a current ratio of 6.49 and a quick ratio of 5.04.

Outset Medical Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.